Angiopoietin levels and outcomes after heart bypass surgery
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how a blood protein called angiopoietin relates to recovery and complications after heart surgery that uses a heart-lung machine. If you’re having scheduled heart bypass-type surgery, your team may take blood samples to see whether these levels can help predict outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older)
- Your planned heart surgery uses a heart-lung machine (cardiopulmonary bypass)
- Your surgery is a first-time (not a redo/repeat) surgery
- Your surgery is scheduled (not emergency/urgent)
- Your planned surgery is not for an aortic root repair
- Your case is not due to endocarditis, aortic dissection, or heart transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
This study looks at a protein in the blood that may help predict kidney damage after heart surgery. It aims to find ways to protect kidney function during and after the operation.
This study tests a technique used during planned heart bypass surgery to see whether it changes substances measured in urine that reflect kidney stress or injury. If you have upcoming elective bypass surgery, your team may collect blood and urine samples to study how your kidneys respond.
This study looks for early signs in your blood or urine that can predict if you might develop kidney damage after heart or blood vessel surgery. It aims to help doctors identify high-risk patients earlier so they can protect their kidneys.
This trial studies ways to control the “pulsatility” (how the blood pressure pulses during circulation) while you are on a heart-lung bypass machine. It may help improve safety and heart function during planned heart surgery.
This trial tests whether giving a medicine called angiotensin II during heart surgery can help prevent acute kidney injury (a sudden drop in kidney function). It is for adults having certain types of heart surgery who have a higher risk of kidney problems.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.